Hyundai Bioscience announced on April 25th that its clinical development plan of oral “Niclosamide Metabolic Anticancer Drug” …
![Niclosamide-based metabolic anticancer drug development](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/04/pexels-photo-7230183.jpeg?resize=400%2C267&ssl=1)
![Niclosamide-based metabolic anticancer drug development](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/04/pexels-photo-7230183.jpeg?resize=400%2C267&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Hyundai Bioscience announced on April 25th that its clinical development plan of oral “Niclosamide Metabolic Anticancer Drug” …